From: DEF6 expression in ovarian carcinoma correlates with poor patient survival
Variable | Overall survival (OS) | Disease-free survival (DFS) | |||||
---|---|---|---|---|---|---|---|
HR | 95 % CI | P -value | HR | 95 % CI | P -value | ||
FIGO stage | |||||||
I | 1.00a | 1.00a | |||||
II | 0.624 | 0.235–1.658 | 0.344 | 0.591 | 0.222–1.575 | 0.293 | |
III | 1.480 | 0.563–3.890 | 0.426 | 1.373 | 0.522–3.609 | 0.520 | |
IV | 3.845 | 0.734–20.133 | 0.111 | 3.496 | 0.671–18.206 | 0.137 | |
DEF6 | 0.025* | 0.016* | |||||
Score 0 and 1 | 1.00a | 1.00a | |||||
Score 2 and 3 | 2.115 | 1.097–4.079 | 2.248 | 1.161–4.352 | |||
p16 | 0.611 | 0.611 | |||||
Score 0, 1 and 2 | 1.00a | 1.00a | |||||
Score 3 | 1.250 | 0.530–2.945 | 1.250 | 0.529–2.953 |